Vaccine roll out: Any delay in nationwide roll-out of the Covid-19 vaccine or any news related to failure of one of the vaccines may sour sentiment, says Narendra Solanki, head of fundamental research at Anand Rathi Shares and Stock Brokers.
Tech view: "Till Nifty holds above 14,750, overall trend remains bullish for a potential move towards 15,500 and 15,750. If it drifts below 15,000 and holds below 14,750 only then the market stance could change for any profit booking decline.Those who are worried from over stretched market move can shift to Option and Option strategy to mitigate their risk and ride the ongoing market momentum with lesser cost," says Chandan Taparia, derivative & technical analyst at Motilal Oswal Financial Services.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)